Science Corp. Names Nevada Sanchez as Executive Vice President of Engineering

ALAMEDA, Calif.--(BUSINESS WIRE)--Science Corporation, the full-stack neural engineering and brain-computer interface (BCI) company focused on restoring and extending life, today announced the appointment of Nevada Sanchez as Executive Vice President of Engineering. Sanchez will provide engineering leadership across the organization and will report directly to Science CEO and co-founder Max Hodak.

Sanchez co-founded Butterfly Network, Inc. (NYSE: BFLY) in 2011, and until recently served as Senior Vice President and Chief Innovation Officer. While there, he conceived and led the development of the world’s first ultrasound system on a chip, building the engineering organization that took the technology from a prototype to a globally deployed platform. His work helped establish Butterfly as a pioneer in semiconductor-based medical imaging.

The appointment comes after Science’s successful $230 million Series C capital raise, and as it begins the European commercial launch of PRIMA, its BCI retinal implant. Science is also accelerating development of its Biohybrid neural interface and Vessel perfusion programs, and expanding the Science Foundry, with its comprehensive MEMS fabrication capabilities.

“We are dedicated to solving some of medicine’s hardest problems through neural engineering. This requires constant innovation at scale and the best minds working together,” said Hodak. “Nevada has spent the past fifteen years creating an entirely new sensing technology at Butterfly and scaling it to a product used by clinicians globally to reveal what was previously invisible. We are thrilled he’s joining us.”

“Science is working on some of the most interesting and consequential engineering problems in medicine: restoring vision with retinal implants, building the next generation of implantable neural interfaces, and developing technologies for long-term organ support,” said Sanchez. “I have tremendous respect for what Max and the Science team have already accomplished, and I look forward to what we can accomplish together, which will change lives around the world.”

Sanchez holds an S.B. in Electrical Engineering and Computer Science, an S.B. in Mathematics with a minor in Physics, and an M.Eng. in Electrical Engineering and Computer Science from MIT. He received the Henry Ford II Scholar Award, given to the top student in the MIT School of Engineering, and was named a Hertz Fellow before leaving academia to co-found Butterfly Network.

Science’s PRIMA retinal implant is the only treatment to have successfully restored form vision to clinical trial patients blinded by late-stage macular degeneration. The PRIMA clinical trial results were featured in The New England Journal of Medicine and on the cover of Time. PRIMA has received a CE (Conformité Européenne) mark under the European Union Medical Device Regulation from DEKRA, authorizing its commercial availability across 30 European countries. An FDA process is also underway.

About Science Corporation

Science Corporation is a vertically-integrated, full-stack neural engineering company. Our mission is to restore and extend life by transcending the limits of biology. We are developing advanced brain-computer interface technologies and devices to address critical unmet medical needs and, longer term, to transform the human condition through neural engineering and advanced perfusion technology. Science is headquartered in Alameda, Calif. For more information please visit: www.science.xyz.